Placental Ras Regulates Inflammation Associated with Maternal Obesity

scientific article published on 08 October 2018

Placental Ras Regulates Inflammation Associated with Maternal Obesity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2018/3645386
P932PMC publication ID6196914
P698PubMed publication ID30402038

P50authorMartha LappasQ59694807
Stella LiongQ37384832
P2093author name stringGillian Barker
P2860cites workThe ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathwayQ24294986
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationQ24616946
Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient miceQ27438116
Proteins regulating Ras and its relativesQ28257295
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Q29617043
The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?Q30404178
Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothersQ33267759
Effect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babiesQ33291574
The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cellsQ33587770
Maternal obesity, inflammation, and developmental programming.Q33747395
Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways.Q33888360
Clinical relevance of KRAS in human cancersQ33959887
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and developmentQ33967144
Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesityQ33976401
Maternal gestational weight gain and offspring weight in adolescenceQ34402636
Obesity and diabetes in the developing world--a growing challengeQ34603178
Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placentaQ34824188
Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesionsQ34943207
Chemical biology tools for regulating RAS signaling complexity in space and timeQ35264345
RAF1 is increased in labouring myometrium and modulates inflammation-induced pro-labour mediators.Q53194890
Activation of NF-kappaB is a novel target of KRAS-induced endometrial carcinogenesis.Q53289113
Ras oncogene and inflammation: partners in crime.Q53674703
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in LondonQ57523561
H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cellsQ73202039
Mitogen-activated protein kinase proteins regulate LPS-stimulated release of pro-inflammatory cytokines and prostaglandins from human gestational tissuesQ80157675
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesisQ80998934
Maternal obesity and markers of inflammation in pregnancyQ84021918
The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetesQ85271008
Decreased STAT3 in human idiopathic fetal growth restriction contributes to trophoblast dysfunctionQ86826605
Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory"Q35579461
An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.Q35858071
TNF-α stimulates System A amino acid transport in primary human trophoblast cells mediated by p38 MAPK signalingQ36247991
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.Q36428213
Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies.Q36508970
Maternal obesity, length of gestation, risk of postdates pregnancy and spontaneous onset of labour at termQ36592386
Cigarette smoking and colorectal cancer risk by KRAS mutation status among older womenQ36656445
Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammationQ36772844
The effect of maternal obesity on the offspringQ36887493
Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cellsQ37019981
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeQ37091901
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based studyQ37340755
Weight status in the first 6 months of life and obesity at 3 years of ageQ37386768
Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancerQ37610817
Maternal obesity is associated with a lipotoxic placental environmentQ37689149
TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytializationQ37699280
KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancerQ37923195
The risk of maternal obesity to the long-term health of the offspringQ38046263
Obesity and Placental Function.Q38687952
Inflammation as a driver and vulnerability of KRAS mediated oncogenesisQ38864070
Future predictions of body mass index and overweight prevalence in Australia, 2005-2025.Q39738391
The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiationQ39958892
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.Q40105282
Placental Pim-1 expression is increased in obesity and regulates cytokine- and toll-like receptor-mediated inflammation.Q40208726
The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activityQ40399733
Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen.Q40540260
Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomasQ40858455
Sounding the alarm: protein kinase cascades activated by stress and inflammationQ41106742
Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.Q42208993
PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranesQ42381281
Cancer: Drug for an 'undruggable' proteinQ42734596
Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitusQ43795799
Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium.Q44575859
Placental structure and inflammation in pregnancies associated with obesity.Q46328759
Identification of human liver cytochrome P450 enzymes responsible for the metabolism of lonafarnib (Sarasar).Q46916966
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.Q47959541
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectobesityQ12174
immunologyQ101929
maternal obesityQ108582152
P304page(s)3645386
P577publication date2018-10-08
P1433published inMediators of InflammationQ2144494
P1476titlePlacental Ras Regulates Inflammation Associated with Maternal Obesity
P478volume2018